Literature DB >> 26998286

Stromal expression of matrix metalloproteinase 2 in cancer-associated fibroblasts is strongly related to human epidermal growth factor receptor 2 status in invasive breast carcinoma.

Xavier Catteau1, Philippe Simon2, Jean-Christophe Noël3.   

Abstract

The peritumoral stroma and cancer-associated fibroblasts (CAFs) have been suggested to play an important role in breast tumorigenesis. The specific immunohistochemical characteristics of the stromal component according to the breast carcinoma subtype surrogates of molecular classes is poorly understood. In the present study, immunohistochemical staining was used to evaluate the expression of matrix metalloproteinase 2 (MMP2), which is one of the most important proteins considered to facilitate tumor invasion, in a series of invasive breast carcinomas according to subtype: Luminal A, luminal B, luminal-HER2, HER2-enriched and triple-negative. A significant increase in MMP2 expression was demonstrated in tumors known to exhibit a more aggressive metastatic behavior, such as luminal HER2 (37%), HER2-enriched (30%) and triple-negative tumors (17%), compared with the luminal A (6%) or luminal B (13%) subtypes. Our data indicated that the CAFs associated with different breast subtypes exhibit different specific properties to facilitate tumor invasion.

Entities:  

Keywords:  breast carcinoma; cancer-associated fibroblasts; human epidermal growth factor receptor-2; luminal; matrix metalloproteinase-2; myofibroblasts; peritumoral stroma

Year:  2015        PMID: 26998286      PMCID: PMC4774431          DOI: 10.3892/mco.2015.721

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  19 in total

Review 1.  Cancer metastasis: building a framework.

Authors:  Gaorav P Gupta; Joan Massagué
Journal:  Cell       Date:  2006-11-17       Impact factor: 41.582

Review 2.  MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment.

Authors:  F J Kohlhapp; A K Mitra; E Lengyel; M E Peter
Journal:  Oncogene       Date:  2015-04-13       Impact factor: 9.867

3.  Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas.

Authors:  J L Jones; P Glynn; R A Walker
Journal:  J Pathol       Date:  1999-10       Impact factor: 7.996

Review 4.  Molecular mechanism underlying the tumor-promoting functions of carcinoma-associated fibroblasts.

Authors:  Yali Han; Yanwen Zhang; Tanghong Jia; Yuping Sun
Journal:  Tumour Biol       Date:  2015-02-15

Review 5.  Matrix metalloproteinase-2 involvement in breast cancer progression: a mini-review.

Authors:  Agnieszka Jezierska; Tomasz Motyl
Journal:  Med Sci Monit       Date:  2009-02

6.  Stromal gene expression predicts clinical outcome in breast cancer.

Authors:  Greg Finak; Nicholas Bertos; Francois Pepin; Svetlana Sadekova; Margarita Souleimanova; Hong Zhao; Haiying Chen; Gulbeyaz Omeroglu; Sarkis Meterissian; Atilla Omeroglu; Michael Hallett; Morag Park
Journal:  Nat Med       Date:  2008-04-27       Impact factor: 53.440

7.  A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer.

Authors:  Pierre Farmer; Hervé Bonnefoi; Pascale Anderle; David Cameron; Pratyaksha Wirapati; Pratyakasha Wirapati; Véronique Becette; Sylvie André; Martine Piccart; Mario Campone; Etienne Brain; Gaëtan Macgrogan; Thierry Petit; Jacek Jassem; Frédéric Bibeau; Emmanuel Blot; Jan Bogaerts; Michel Aguet; Jonas Bergh; Richard Iggo; Mauro Delorenzi
Journal:  Nat Med       Date:  2009-01-04       Impact factor: 53.440

Review 8.  Stromal myofibroblasts are drivers of invasive cancer growth.

Authors:  Olivier De Wever; Pieter Demetter; Marc Mareel; Marc Bracke
Journal:  Int J Cancer       Date:  2008-11-15       Impact factor: 7.396

Review 9.  Collagen induced MMP-2 activation in human breast cancer.

Authors:  E W Thompson; M Yu; J Bueno; L Jin; S N Maiti; F L Palao-Marco; H Pulyaeva; J W Tamborlane; R Tirgari; I Wapnir
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

10.  Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study.

Authors:  Harri Sihto; Johan Lundin; Mikael Lundin; Tiina Lehtimäki; Ari Ristimäki; Kaija Holli; Liisa Sailas; Vesa Kataja; Taina Turpeenniemi-Hujanen; Jorma Isola; Päivi Heikkilä; Heikki Joensuu
Journal:  Breast Cancer Res       Date:  2011-09-13       Impact factor: 6.466

View more
  6 in total

Review 1.  Mutual concessions and compromises between stromal cells and cancer cells: driving tumor development and drug resistance.

Authors:  Pritish Nilendu; Sachin C Sarode; Devashree Jahagirdar; Ishita Tandon; Shankargouda Patil; Gargi S Sarode; Jayanta K Pal; Nilesh Kumar Sharma
Journal:  Cell Oncol (Dordr)       Date:  2018-07-19       Impact factor: 6.730

2.  Preexposure of MCF-7 breast cancer cell line to dexamethasone alters the cytotoxic effect of paclitaxel but not 5-fluorouracil or epirubicin chemotherapy.

Authors:  Frederic Buxant; Nadège Kindt; Jean-Christophe Noël; Guy Laurent; Sven Saussez
Journal:  Breast Cancer (Dove Med Press)       Date:  2017-03-16

Review 3.  The Functional Role of Extracellular Matrix Proteins in Cancer.

Authors:  Nadezhda V Popova; Manfred Jücker
Journal:  Cancers (Basel)       Date:  2022-01-04       Impact factor: 6.639

4.  Role of tumor microenvironment in triple-negative breast cancer and its prognostic significance.

Authors:  Tianjian Yu; Genhong Di
Journal:  Chin J Cancer Res       Date:  2017-06       Impact factor: 5.087

5.  Identification of an energy metabolism‑related gene signature in ovarian cancer prognosis.

Authors:  Lei Wang; Xiuqin Li
Journal:  Oncol Rep       Date:  2020-03-17       Impact factor: 3.906

6.  Alterations in Immune-Related Genes as Potential Marker of Prognosis in Breast Cancer.

Authors:  Bei Li; Rongxin Geng; Qi Wu; Qian Yang; Si Sun; Shan Zhu; Zhiliang Xu; Shengrong Sun
Journal:  Front Oncol       Date:  2020-03-12       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.